SEC Form 4 · accession 0000874015-16-000150
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth L Hougen
Officer — SVP, Finance & CFO
Period of report
Dec 5, 2016
Accepted (ET)
Dec 7, 2016 · 7:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 5, 2016 | M | 2,500 | $11.27 | A | 9,048 | D | |
| Common StockF1 | Dec 5, 2016 | S | 2,500 | $46.05 | D | 6,548 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $11.27 | Dec 5, 2016 | M | 2,500 | D | Jan 4, 2014 | Jan 3, 2017 | Common Stock | 2,500 | 0 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option that was scheduled to expire on 1/3/2017. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 2/3/2015.